A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Condition:   Asthma Interventions:   Drug: AZD8154 nebulizer suspension, 20 mg/mL;   Drug: Placebo Sponsors:   AstraZeneca;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials